Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients with type 2 diabetes mellitus and coronary artery disease (Q38436685)
Jump to navigation
Jump to search
scientific article published on 06 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients with type 2 diabetes mellitus and coronary artery disease |
scientific article published on 06 February 2014 |
Statements
1 reference
Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients with type 2 diabetes mellitus and coronary artery disease (English)
1 reference
Liam M McCormick
1 reference
Anna C Kydd
1 reference
Philip A Read
1 reference
Liam S Ring
1 reference
Simon J Bond
1 reference
Stephen P Hoole
1 reference
David P Dutka
1 reference
6 February 2014
1 reference
1 reference
Identifiers
1 reference